Single-dose Radiotherapy Services Market

Single-dose Radiotherapy Services Market Outlook 2032

The global single-dose radiotherapy services market size was USD 7.9 Billion in 2023 and is projected to reach USD 15.1 Billion by 2032, expanding at a CAGR of 7.5% during 2024–2032. The market growth is attributed to the advancements in radiotherapy technology and growing awareness of the benefits of single-dose regimens.

Increasing demand for efficient and targeted cancer treatments led to a high use of single-dose radiotherapy services, thereby propelling the market. The usability of single-dose radiotherapy services is expanding due to the advancement of innovative treatment modalities, including image-guided radiotherapy (IGRT) and intensity-modulated  radiation therapy (IMRT), which provide precise and personalized treatment options. Furthermore, the growing preference for minimally invasive treatment modalities boosts the adoption of single-dose radiotherapy services.

• As per the report published by the National Library of Medicine in January 2023, over 11.1% of medical procedures performed in 2017 were minimally invasive.
  

  Get Free Sample Report
  

Impact of Artificial Intelligence (AI) in Single-dose Radiotherapy Services Market

The use of artificial intelligence is likely to boost the single-dose radiotherapy services market. AI-powered algorithms analyze vast amounts of patient data to generate personalized treatment plans tailored to individual patient characteristics and tumor biology. Furthermore, AI-driven decision support tools assist radiation oncologists in real-time during treatment delivery, ensuring precise targeting.

Single-dose Radiotherapy Services Market Dynamics

Get Free Sample Report

Major Drivers

Increasing incidence of cancer cases worldwide is anticipated to drive the market during the forecast period. Single-dose radiotherapy is gaining widespread usage due to its numerous advantages over traditional multi-dose regimens. These advantages include reduced treatment time, minimized side effects, and enhanced patient convenience. For instance, according to the WHO report on February 3, 2022, around one in six global deaths in 2020 were caused by cancer, resulting in approximately 10 million deaths. Moreover, advancements in technology, such as image-guided radiotherapy (IGRT) and intensity-modulated radiation therapy (IMRT) further propelling the adoption of single-dose radiotherapy services.

Existing Restraints

High cost of single-dose radiotherapy services is expected to hinder the market. The procuring and maintaining advanced radiotherapy equipment, such as linear accelerators is high for small healthcare facilities, which decreases the adoption of single-dose radiotherapy services. Moreover, compliance with evolving regulatory requirements adds cost to the development and deployment of single-dose radiotherapy services, which further hinders the market during the assessment period.

Emerging Opportunities

­Ongoing research and advancement in single-dose radiotherapy are expected to create immense opportunities for the players competing in the market. Manufacturers are focusing on aimed at enhancing the efficacy and safety of single-dose radiotherapy for effective treatment services. Moreover, governments and private healthcare organizations are investing heavily in upgrading existing radiotherapy facilities and procuring advanced equipment to meet the growing demand for cancer treatment services. These factors are boosting the market during the forecast period.

Scope of the Single-dose Radiotherapy Services Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Single-dose Radiotherapy Services Market Segment Insights

Indication Segment Analysis

Based on indication, the single-dose radiotherapy services market is divided into prostate cancer and breast cancer. The prostate cancer segment held a major share of the market in 2023, due to the growing prevalence of these types of cancers fueling the demand for radiotherapy services.

Single-dose radiotherapy offers advantages such as reduced treatment duration and improved patient comfort compared to traditional multi-dose regimens making it an attractive option for prostate cancer patients. Furthermore, increasing awareness campaigns and screening initiatives for prostate cancer have contributed to the growing demand for single-dose radiotherapy services.

The breast cancer segment is expected to expand at a significant pace in the coming years, owing to the rising women population suffering from breast cancer. Single-dose radiotherapy services are a widely used option for delivering precise radiation doses while minimizing damage to surrounding healthy tissues. Moreover, advancements in radiotherapy technology for breast cancer are improving treatment planning and delivery, making single-dose radiotherapy increasingly feasible and effective, thereby boosting their adoption in various healthcare settings.

Get Free Sample Report

Therapy Segment Analysis

On the basis of therapy, the global market is segregated into external beam radiology and internal beam radiology. The external beam radiology segment held the largest market share in 2023, as they offer precise delivery of radiation doses to targeted tumors while minimizing damage to healthy tissues.

Single-dose radiotherapy within the external beam radiology modality provides shorter treatment duration and fewer side effects than traditional multi-dose regimens. Furthermore, advancements in external beam radiotherapy technology, such as image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) further improved treatment precision and efficacy, further boosting the utilization of single-dose radiotherapy services.

The internal beam radiology segment is anticipated to expand at a substantial CAGR during the forecast period, owing to its ability to precisely deliver radiation doses while sparing surrounding tissues. Single-dose radiotherapy and internal beam radiology are suitable for treating localized tumors or small volumes of disease, as they offer high dose conformity and rapid dose fall-off. Additionally, increasing adoption of brachytherapy for various cancer indications is expected to propel the segment.

Service Provider Segment Analysis

Based on service provider, the single-dose radiotherapy services market is segmented into hospitals, specialized cancer institutes, and radiotherapy centers. The specialized cancer institutes segment is projected to register a robust growth rate during the assessment years.

Specialized cancer institutes offer comprehensive and specialized care tailored to the unique needs of cancer patients. These institutes often have dedicated radiotherapy centers equipped with modern technology and a multidisciplinary team of oncologists, radiation therapists, and support staff experienced in delivering specialized radiotherapy treatments. Furthermore, the increasing prevalence of cancer and the growing demand for specialized cancer care are likely to fuel the segment during the forecast period.

Get Free Sample Report

Regional Outlook

In terms of region, the global single-dose radiotherapy services market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to well-established radiotherapy facilities and a high adoption of advanced medical technologies. Additionally, favorable reimbursement policies and insurance coverage for radiotherapy treatments have facilitated patient access to single-dose radiotherapy services in the region.

The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to the increasing incidence of cancer cases and the growing aging population. For instance, according to a report published by the National Library of Medicine on January 30, 2022, the incidence of cancer in Asia was 169.1 per 100,000 people in 2020, accounting for 49.3% of global cancer cases. Growing governments and healthcare organizations initiatives to expand access to cancer care and improve treatment outcomes are likely to boost the adoption of single-dose radiotherapy in the region.

Get Free Sample Report

Segments

The single-dose radiotherapy services market has been segmented on the basis of

Indication

• Prostate Cancer
• Breast Cancer

Therapy

• External Beam Radiology
• Internal Beam Radiology

Service Provider

• Hospitals
• Specialized Cancer Institutes
• Radiotherapy Centers

Region

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Accuray Incorporated
• Hitachi, Ltd
• Elekta AB
• GenesisCare
• IBA Worldwide
• Provision Healthcare
• RaySearch Laboratories
• Varian Medical Systems, Inc.
• ViewRay, Inc

Competitive Landscape

Key players competing in the global single-dose radiotherapy services market are Accuray Incorporated; Elekta AB; GenesisCare; Hitachi, Ltd; IBA Worldwide; Provision Healthcare; RaySearch Laboratories; Varian Medical Systems, Inc.; and ViewRay, Inc.

These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base worldwide.

• On March 28, 2024, Elekta, a global manufacturer of precision radiation therapy solutions, announced a partnership with Merck & Co., Inc., an US-based multinational pharmaceutical company. The objective of this collaboration is to improve kidney cancer care with the help of digital solutions. These companies are focusing on developing a digital module for patients that allows them to stay connected with their care team.